Bristol-Myers Squibb Co (BMY)
44.02
+0.12
(+0.27%)
USD |
NYSE |
May 07, 16:00
44.03
+0.01
(+0.02%)
After-Hours: 17:27
Bristol-Myers Squibb Cash from Financing (TTM): 8.278B for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.278B |
| December 31, 2023 | -9.416B |
| September 30, 2023 | -13.63B |
| June 30, 2023 | -13.01B |
| March 31, 2023 | -14.36B |
| December 31, 2022 | -16.96B |
| September 30, 2022 | -17.68B |
| June 30, 2022 | -14.92B |
| March 31, 2022 | -14.58B |
| December 31, 2021 | -16.22B |
| September 30, 2021 | -8.774B |
| June 30, 2021 | -9.581B |
| March 31, 2021 | -7.392B |
| December 31, 2020 | -1.151B |
| September 30, 2020 | -12.31B |
| June 30, 2020 | -10.66B |
| March 31, 2020 | 8.596B |
| December 31, 2019 | 7.621B |
| September 30, 2019 | 14.72B |
| June 30, 2019 | 14.94B |
| March 31, 2019 | -4.342B |
| December 31, 2018 | -3.535B |
| September 30, 2018 | -4.309B |
| June 30, 2018 | -4.295B |
| March 31, 2018 | -4.286B |
| Date | Value |
|---|---|
| December 31, 2017 | -4.077B |
| September 30, 2017 | -3.33B |
| June 30, 2017 | -3.17B |
| March 31, 2017 | -2.716B |
| December 31, 2016 | -2.653B |
| September 30, 2016 | -3.407B |
| June 30, 2016 | -3.561B |
| March 31, 2016 | -3.892B |
| December 31, 2015 | -3.624B |
| September 30, 2015 | -2.496B |
| June 30, 2015 | -2.324B |
| March 31, 2015 | -1.927B |
| December 31, 2014 | -2.437B |
| September 30, 2014 | -1.495B |
| June 30, 2014 | -1.587B |
| March 31, 2014 | -2.216B |
| December 31, 2013 | -1.068B |
| September 30, 2013 | -2.737B |
| June 30, 2013 | -3.806B |
| March 31, 2013 | -3.541B |
| December 31, 2012 | -4.333B |
| September 30, 2012 | -4.129B |
| June 30, 2012 | -3.144B |
| March 31, 2012 | -2.801B |
| December 31, 2011 | -2.657B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-17.68B
Minimum
Sep 2022
14.94B
Maximum
Jun 2019
-6.325B
Average
-10.12B
Median
Cash from Financing (TTM) Benchmarks
| Amgen Inc | -2.169B |
| Gilead Sciences Inc | -5.08B |
| Johnson & Johnson | -21.42B |
| Karuna Therapeutics Inc (DELISTED) | 483.37M |
| 2seventy bio Inc | 127.39M |